EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives

Daniel Arcuschin de Oliveira, Melissa Yoshimi Sakamoto Maeda Nisimoto, Jaciara Moreira Sodré Hunnicutt, Eduarda Massa Sartori, Amanda Fáris Marques, Francisco Macedo Paschoal, Luciana Cavalheiro Marti, Miriam Galvonas Jasiulionis, Miguel Sabino Neto, Renato Santos de Oliveira Filho

Oncology Research · 2026 · 34 (6) · 1-10

DOI: 10.32604/or.2026.077913 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Daniel Arcuschin de Oliveira und 9 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma and Skin Tumors Sector, Plastic Surgery Discipline, Escola Paulista de Medicina, Universidade Federal de São Paulo EPM/UNIFESP, Rua Botucatu…. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Epigenesis, Genetic, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinEpigenesis, GeneticMelanomaSkin NeoplasmsHumansAnimalsGene Expression Regulation, NeoplasticMolecular Targeted TherapyMutation

Stichwörter der Autor:innen

EZH2 inhibitorsEnhancer of Zeste Homolog (EZH)2acral lentiginous melanoma (ALM)tazemetostattherapy resistancetrimethylation of histone H3 on lysine 27 (H3K27me3)

Substanzen

Enhancer of Zeste Homolog 2 ProteinEZH2 protein, human

Autor:innen und Institutionen

  • Melanoma and Skin Tumors Sector, Plastic Surgery Discipline, Escola Paulista de Medicina, Universidade Federal de São Paulo EPM/UNIFESP, Rua Botucatu, 740, São Paulo, SP, Brazil.
  • Dermatology Discipline, FMABC University Center, Príncipe de Gales Street, 821, Santo André, SP, Brazil.
  • Department of Experimental Research, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, Morumbi, São Paulo, SP, Brazil.
  • Department of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo EPM/UNIFESP, Rua Botucatu, 740, São Paulo, SP, Brazil.

Zitieren

APA

de Oliveira, D. A., Nisimoto, M. Y. S. M., Hunnicutt, J. M. S., Sartori, E. M., Marques, A. F., Paschoal, F. M., Marti, L. C., Jasiulionis, M. G., Neto, M. S., & Filho, R. S. O. (2026). EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives. Oncology Research, 34(6), 1-10. https://doi.org/10.32604/or.2026.077913

Vancouver

de Oliveira DA, Nisimoto MYSM, Hunnicutt JMS, Sartori EM, Marques AF, Paschoal FM, et al. EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives. Oncology Research. 2026;34(6):1-10. doi:10.32604/or.2026.077913

BibTeX
@article{deOliveira2026,
  author = {de Oliveira, Daniel Arcuschin and Nisimoto, Melissa Yoshimi Sakamoto Maeda and Hunnicutt, Jaciara Moreira Sodré and Sartori, Eduarda Massa and Marques, Amanda Fáris and Paschoal, Francisco Macedo and Marti, Luciana Cavalheiro and Jasiulionis, Miriam Galvonas and Neto, Miguel Sabino and Filho, Renato Santos de Oliveira},
  title = {EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic Perspectives},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {6},
  pages = {1--10},
  doi = {10.32604/or.2026.077913}
}
Kostenlos starten →